Brind.

Partnership between AstraZeneca and SOPHiA GENETICS SA focuses on AI-powered predictive models for the biopharma sector.

2 reports, 2 independent Updated Aug 6
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Partnership between AstraZeneca and SOPHiA GENETICS SA focuses on AI-powered predictive models for the biopharma sector.

Who's involved

What this event is mainly about
AstraZeneca

How it developed

Newest first. Tap a step to see who reported it.
  1. Sophia Genetics announced a multi-year AI breast cancer partnership with AstraZeneca, leveraging its technology for biopharma applications.Sub-event
  2. AstraZeneca partners with SOPHiA GENETICS SA to leverage AI for predictive modeling in biopharma.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • GuruFocus.comSophia Genetics SA (SOPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... Release Date: August 05, 2025 For the complete transcript of the earnings call, please refer to the
  • PR NewswireSOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a